Walvax Biotechnology Co., Ltd. (SHE:300142)
China
· Delayed Price · Currency is CNY 12.91
+0.06 (0.47%)
Apr 29, 2026, 1:15 PM CST
Walvax Biotechnology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 2,394 | 2,413 | 2,804 | 4,106 | 5,079 | 3,452 | Upgrade
|
| Other Revenue | 5.72 | 5.72 | 17.86 | 7.92 | 7.65 | 10.5 | Upgrade
|
| Revenue | 2,400 | 2,418 | 2,821 | 4,114 | 5,086 | 3,463 | Upgrade
|
| Revenue Growth (YoY) | -10.59% | -14.29% | -31.41% | -19.12% | 46.89% | 17.82% | Upgrade
|
| Cost of Revenue | 639.95 | 631.8 | 742.2 | 749.39 | 673.14 | 403.54 | Upgrade
|
| Gross Profit | 1,760 | 1,786 | 2,079 | 3,364 | 4,413 | 3,059 | Upgrade
|
| Selling, General & Admin | 1,225 | 1,245 | 1,399 | 1,817 | 2,302 | 1,636 | Upgrade
|
| Research & Development | 268.71 | 291.81 | 595.77 | 776.43 | 922.25 | 616.36 | Upgrade
|
| Other Operating Expenses | -1.87 | -3.46 | -4.12 | -100 | 16.48 | 19.83 | Upgrade
|
| Operating Expenses | 1,520 | 1,682 | 2,055 | 2,533 | 3,239 | 2,267 | Upgrade
|
| Operating Income | 240.26 | 104.33 | 24.01 | 831.05 | 1,174 | 792.22 | Upgrade
|
| Interest Expense | -7.56 | -0.91 | -8.43 | -5.95 | -7.11 | -5.77 | Upgrade
|
| Interest & Investment Income | 65.33 | 69.78 | 66.75 | 81.35 | 81.82 | 103.29 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.63 | -2.63 | 4.05 | 3.06 | 0.82 | -0.22 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.84 | 2.34 | 169.74 | -63.64 | -75.39 | 33.88 | Upgrade
|
| EBT Excluding Unusual Items | 293.46 | 172.91 | 256.12 | 845.86 | 1,174 | 923.4 | Upgrade
|
| Gain (Loss) on Sale of Investments | -3.52 | 29.68 | -98.34 | -234.75 | -199.33 | -280.74 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.04 | 0.08 | -1.77 | -0.83 | -0.38 | 0.23 | Upgrade
|
| Asset Writedown | -49.55 | -88.25 | -7.68 | -11.31 | -1.66 | -5.11 | Upgrade
|
| Other Unusual Items | 69.39 | 51.69 | 36.17 | - | 97.8 | 71.15 | Upgrade
|
| Pretax Income | 309.82 | 166.11 | 184.5 | 598.98 | 1,070 | 708.95 | Upgrade
|
| Income Tax Expense | 50.57 | 40.96 | 10.1 | 87.65 | 132.24 | 107.59 | Upgrade
|
| Earnings From Continuing Operations | 259.25 | 125.16 | 174.4 | 511.33 | 938.23 | 601.35 | Upgrade
|
| Net Income to Company | 259.25 | 125.16 | 174.4 | 511.33 | 938.23 | 601.35 | Upgrade
|
| Minority Interest in Earnings | 26.52 | 52.58 | -32.24 | -91.93 | -209.57 | -173.6 | Upgrade
|
| Net Income | 285.77 | 177.74 | 142.16 | 419.39 | 728.65 | 427.75 | Upgrade
|
| Net Income to Common | 285.77 | 177.74 | 142.16 | 419.39 | 728.65 | 427.75 | Upgrade
|
| Net Income Growth | 118.68% | 25.03% | -66.10% | -42.44% | 70.35% | -57.36% | Upgrade
|
| Shares Outstanding (Basic) | 1,611 | 1,600 | 1,599 | 1,600 | 1,603 | 1,569 | Upgrade
|
| Shares Outstanding (Diluted) | 1,611 | 1,600 | 1,599 | 1,600 | 1,604 | 1,573 | Upgrade
|
| Shares Change (YoY) | 1.49% | 0.05% | -0.06% | -0.21% | 1.93% | 0.90% | Upgrade
|
| EPS (Basic) | 0.18 | 0.11 | 0.09 | 0.26 | 0.45 | 0.27 | Upgrade
|
| EPS (Diluted) | 0.18 | 0.11 | 0.09 | 0.26 | 0.45 | 0.27 | Upgrade
|
| EPS Growth | 115.48% | 24.97% | -66.08% | -42.32% | 67.12% | -57.74% | Upgrade
|
| Free Cash Flow | 98.37 | -18.62 | 486.49 | 188.25 | 110.31 | -398.21 | Upgrade
|
| Free Cash Flow Per Share | 0.06 | -0.01 | 0.30 | 0.12 | 0.07 | -0.25 | Upgrade
|
| Dividend Per Share | 0.155 | 0.155 | 0.010 | 0.010 | 0.010 | 0.027 | Upgrade
|
| Dividend Growth | 1450.00% | 1450.00% | - | - | -62.96% | -61.43% | Upgrade
|
| Gross Margin | 73.33% | 73.87% | 73.69% | 81.78% | 86.77% | 88.35% | Upgrade
|
| Operating Margin | 10.01% | 4.31% | 0.85% | 20.20% | 23.08% | 22.88% | Upgrade
|
| Profit Margin | 11.91% | 7.35% | 5.04% | 10.20% | 14.32% | 12.35% | Upgrade
|
| Free Cash Flow Margin | 4.10% | -0.77% | 17.24% | 4.58% | 2.17% | -11.50% | Upgrade
|
| EBITDA | 625.96 | 485.6 | 387.61 | 1,121 | 1,422 | 927.65 | Upgrade
|
| EBITDA Margin | 26.08% | 20.08% | 13.74% | 27.25% | 27.96% | 26.79% | Upgrade
|
| D&A For EBITDA | 385.7 | 381.28 | 363.59 | 289.97 | 248.4 | 135.43 | Upgrade
|
| EBIT | 240.26 | 104.33 | 24.01 | 831.05 | 1,174 | 792.22 | Upgrade
|
| EBIT Margin | 10.01% | 4.31% | 0.85% | 20.20% | 23.08% | 22.88% | Upgrade
|
| Effective Tax Rate | 16.32% | 24.65% | 5.48% | 14.63% | 12.35% | 15.18% | Upgrade
|
| Revenue as Reported | 2,400 | 2,418 | 2,821 | 4,114 | 5,086 | - | Upgrade
|
| Advertising Expenses | - | 28.28 | 42.66 | 78.01 | 94.83 | 24.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.